New neuropathy treatment guidelines.
These expert guidelines for treating neuropathic pain are particularly important, since most of the treatments are off label--meaning that they have been approved by the FDA but not for this particular purpose. These guidelines will help educate doctors about what treatments are best, and should also help in getting insurance reimbursements for care that clearly represents expert consensus but is not in the official labeling at this time.
James
John S
JS
D000700:Analgesics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
D000700:Analgesics